Alpa Laboratories' Stock Reaches All-Time High, Outperforms Sector and Market Averages
Alpa Laboratories, a microcap pharmaceutical company, has been making waves in the stock market with its stock price reaching an all-time high on September 5th, 2024. The company's stock has been consistently outperforming the sector and market averages, with a 3.56% increase from its 52-week high and a 'Hold' rating from MarketsMojo. Its strong performance, consecutive gains, and trading above moving averages indicate a positive trend for investors.
Alpa Laboratories, a microcap pharmaceutical company, has been making waves in the stock market as its share price reached an all-time high on September 5th, 2024. The company's stock has been performing well, with a 3.56% increase from its 52-week high of Rs 115. This positive trend has been noticed by MarketsMOJO, who have given the stock a 'Hold' rating.
In today's trading, Alpa Laboratories has outperformed the sector by 5.35%, showing its strong potential in the pharmaceutical industry. The stock has also been on a consecutive gain for the past 3 days, with a 7.71% increase in returns during this period. Its intraday high of Rs 111.95, which is a 6.98% increase, further solidifies its strong performance.
Alpa Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. This is a good sign for investors, as it shows the company's stock is consistently performing well.
In comparison to the Sensex, Alpa Laboratories has shown a remarkable 1-year performance of 51.65%, while the Sensex has only seen a 25.13% increase. This further highlights the company's strong performance and potential for growth in the future.
Overall, Alpa Laboratories has been making significant strides in the stock market, with its stock price reaching an all-time high and consistently outperforming the sector and market averages. With its positive performance and strong potential, it is definitely a company to keep an eye on in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
